🟢 First Tracks Biotherapeutics is trading 5.5% up today amid broader biotech momentum

First Tracks Biotherapeutics is trading 5.5% up now at $41.14, with broader biotech-sector momentum the clearest explanation.

• Shares rose from the September 21 close of $38.99; XBI was up 2.07% during the regular session.
• No fresh company-specific announcement, filing, earnings update, or analyst action dated September 22 was identified.
• Latest coverage remains positive, including recent Buy initiations and elevated price targets; the move appears sector-led rather than driven by a new First Tracks catalyst.